These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 10298317)
21. 1993 drug dollar volume leaders in hospital pharmacies. Gwinn B Hosp Pharm; 1994 Apr; 29(4):340-4, 362. PubMed ID: 10171823 [No Abstract] [Full Text] [Related]
22. Drugmakers fight for good name. Stakes high, challenges many for providers who seek generic products. Becker C Mod Healthc; 2001 Aug; 31(35):28-33, 1. PubMed ID: 11550428 [TBL] [Abstract][Full Text] [Related]
23. Marketing to the pharmacist. Zilz DA Med Mark Media; 1981 Jul; 16(7):8, 10, 14. PubMed ID: 10317131 [No Abstract] [Full Text] [Related]
24. A survey of hospital and clinic pharmacy systems. Peterson D Comput Healthc; 1983 Apr; 4(4):44-5, 50. PubMed ID: 10298919 [No Abstract] [Full Text] [Related]
25. Emergency medicine: a basic bibliography (#52). Levy DB Hosp Pharm; 1988 Nov; 23(11):1040. PubMed ID: 10302984 [No Abstract] [Full Text] [Related]
28. Reporting drug product defects--JCAHO. Hoffmann RP Hosp Pharm; 1989 Feb; 24(2):143-4. PubMed ID: 10318199 [No Abstract] [Full Text] [Related]
29. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers. Fleuranceau-Morel P Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550 [TBL] [Abstract][Full Text] [Related]
30. Hospital pharmacy and the pharmaceutical industry. Kizer-Steinberg S Am J Hosp Pharm; 1977 Oct; 34(10):1052-5. PubMed ID: 920737 [No Abstract] [Full Text] [Related]
32. Other viewpoints on the effects of cost controls. Davis NM Hosp Pharm; 1983 Aug; 18(8):400-5, 409. PubMed ID: 10261790 [No Abstract] [Full Text] [Related]
33. Drug Price Index declines as prices weaken for older drugs. Hosp Mater Manage; 1986 May; 11(5):21-2. PubMed ID: 10277138 [No Abstract] [Full Text] [Related]
34. What hospital pharmacists expect from drug wholesalers. Higgins DF Pharm Times; 1979 Oct; 45(10):65-7. PubMed ID: 10244410 [No Abstract] [Full Text] [Related]
35. The effectiveness of pharmaceutical promotion to hospital pharmacists. Demeritt GA Am J Hosp Pharm; 1966 Jan; 23(1):13-23. PubMed ID: 5901349 [No Abstract] [Full Text] [Related]
36. Drug samples in the hospital revisited. Lipman AG Hosp Formul; 1987 Feb; 22(2):123. PubMed ID: 10280288 [No Abstract] [Full Text] [Related]
37. Pharmacy directors fear that anti-resale law may be point of no return for drugs. Wagner M Mod Healthc; 1988 Sep; 18(40):38. PubMed ID: 10290435 [No Abstract] [Full Text] [Related]
38. Parenteral drug association. Bull Parenter Drug Assoc; 1966; 20(3):85-99. PubMed ID: 5326401 [No Abstract] [Full Text] [Related]
39. Availability of emergency drugs for pharmacists. Graham RC Can Pharm J; 1981 Jan; 114(1):13-4. PubMed ID: 10317048 [No Abstract] [Full Text] [Related]
40. The Food and Drug Administration perspective: use of an investigational drug in a medical emergency. Schultheis LW; Rappaport BA Anesth Analg; 2007 Mar; 104(3):479-80. PubMed ID: 17312189 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]